Valuation : Bould Opportunities PLC

Market Cap 5.71K 4.91K 4.61K 4.22K 7.87K 539K 7.93K 54.51K 21.23K 276K 21.43K 20.96K 888K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -67.36K -63.21K -57.84K -108K -7.4M -109K -748K -291K -3.78M -294K -288K -12.18M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 2021-05-13
Chief Tech/Sci/R&D Officer 61 2025-01-01
Director TitleAgeSince
Director/Board Member 45 2019-01-28
Chairman 70 2019-05-20
Director/Board Member 61 2021-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+24.32% - - 3.54M
-0.64%-3.89%-1.17%+99.61% 9.77B
+1.32%-8.95%+211.05%+227.23% 2.31B
+1.20%-1.87%-32.17%-41.64% 2.07B
+1.04%-5.61%-12.24%-27.35% 1.71B
+0.20%+1.02%-24.39%-6.77% 987M
-7.16%-5.73%+77.59%+46.58% 905M
+8.31%+17.36%+36.15%+152.35% 894M
-0.50%+5.00%+98.61% - 796M
+1.00%-0.30%-11.64%+26.56% 716M
Average +0.48%+3.36%+37.98%+59.57% 2.02B
Weighted average by Cap. +0.13%-1.93%+26.63%+80.35%

Financials

2019 2020
Net sales - -
Net income -832K -716K -672K -615K -1.15M -78.65M -1.16M -7.95M -3.09M -40.19M -3.12M -3.06M -129M -306K -263K -247K -226K -422K -28.93M -425K -2.92M -1.14M -14.78M -1.15M -1.12M -47.61M
Net Debt -378K -325K -305K -279K -521K -35.73M -525K -3.61M -1.41M -18.26M -1.42M -1.39M -58.81M -84K -72.27K -67.82K -62.05K -116K -7.94M -117K -802K -312K -4.06M -315K -309K -13.07M
Logo Bould Opportunities PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-